【摘 要】
：
Nuclear receptors are a class of cellular proteins that are responsible for sensing the ligand substances such as steroid and thyroid hormones and certain other molecules.In response to the ligands,th
【机 构】
：
Frontier Science Innovation Center Osaka Prefecture University Japan
【出 处】
：
中国上海第七届国际新药发明科技年会
论文部分内容阅读
Nuclear receptors are a class of cellular proteins that are responsible for sensing the ligand substances such as steroid and thyroid hormones and certain other molecules.In response to the ligands,these receptors work in concert with other proteins to regulate the expression of specific genes as transcription factors,thereby controlling the development,homeostasis,and metabolism of the organism.As the expression of numerous genes is regulated by nuclear receptors,the exogenous substances acting like intrinsic ligands can cause significant effects on the organism.Many of these regulated genes are associated with various diseases; therefore,nuclear receptors have been the molecular targets of many approved pharmaceuticals.Of the approximately 50 known human nuclear receptors,some receptors such as FXR,LXR,and PPAR bind to a number of metabolic intermediates such as fatty acids,bile acids and sterols.
其他文献
Studies over the past several decades support the hypothesis that enhanced external counterpulsation (EECP) can provide long-term benefits in patients with angina secondary to chronic coronary disease
Enhanced external counterpulsation (EECP) is a noninvasive treatment modality,which can increase arterial blood flow in peripheral and coronary arterial disease.Several studies have demonstrated an in
This paper is presented as an overview of the Enhanced External Counterpulsation papers published in the October and November 1997 issue of Cardiovascular Reviews and Reports.
This review traces the evolution of external counterpulsation from its beginning to the early 1990s.The term counterpulsation derives from the dual hemodynamic goals of this treatment:to reduce the af
This paper summarizes the status of EECP in the treatment of patients with angina pectoris.It underlines the fact that this treatment is particularly indicated in patients at high risk for revasculari
Enhanced external counterpulsation (EECP) is an effective noninvasive treatment for chronic stable angina.Despite intensive risk factor modification,a patient required two surgical coronary revascular
There are many patients in whom repeat (or initial) PTCA and/or CABG are not appropriate and in whom aggressive medical therapy still fails to maintain a quality of life that patients are comfortable
A critical step of drug discovery is the establishment of robust cellular and molecular assays to test drug effects and specificity.Chromatin immunoprecipitation (ChIP) is a robust technique for study